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Abstract: Low circulating adiponectin levels may contribute to higher diabetes risk among Mexican
Americans (MA) compared to non-Latino whites (NLW). Our objective was to determine if among
young healthy adult MAs have lower adiponectin than NLWs, independent of differences in
adiposity. In addition, we explored associations between adiponectin and diet. This was an
observational, cross-sectional study of healthy MA and NLW adults living in Colorado (U.S.A.). We
measured plasma total adiponectin, adiposity (BMI, and visceral adipose tissue), insulin sensitivity
(IVGTT), and self-reported dietary intake in 43 MA and NLW adults. Mean adiponectin levels
were 40% lower among MA than NLW (5.8 ˘ 3.3 vs. 10.7 ˘ 4.2 µg/mL, p = 0.0003), and this
difference persisted after controlling for age, sex, BMI, and visceral adiposity. Lower adiponectin
in MA was associated with lower insulin sensitivity (R2 = 0.42, p < 0.01). Lower adiponectin was
also associated with higher dietary glycemic index, lower intake of vegetables, higher intake of
trans fat, and higher intake of grains. Our findings confirm that ethnic differences in adiponectin
reflect differences in insulin sensitivity, but suggest that these are not due to differences in adiposity.
Observed associations between adiponectin and diet support the need for future studies exploring
the regulation of adiponectin by diet and other environmental factors.
Keywords: adiponectin; insulin resistance; diet; Mexican American
1. Introduction
Adiponectin is an insulin-sensitizing hormone produced and released into the circulation
primarily by adipose tissue [1]. Low adiponectin levels are associated with increased risk of type 2
diabetes in a dose-dependent relationship, across diverse populations, including Hispanics [2–4]. In a
sub-analysis of the Diabetes Prevention Program (DPP) study, a ~3 µg/mL lower baseline adiponectin
level in individuals with pre-diabetes corresponded to a 20%–40% higher rate of progression to
diabetes [3]. Adiponectin levels vary by ethnicity and have been reported to be lower among
Hispanics than non-Latino whites [3,5], raising the possibility that ethnic differences in adiponectin
levels contribute to differences in diabetes risk.
Several gaps in knowledge related to adiponectin in Hispanics still remain. First, previous
studies have compared adiponectin levels in non-Latino whites to those in Hispanics as a group,
rather than studying individuals from one single Hispanic-origin group. Since the term “Hispanic”
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includes individuals from many different geographical areas, with varied genetic backgrounds, and
different cultural practices (language, diet, etc.), one would expect that biological factors differ
as well. In fact, in the United States, prevalence of diabetes is much higher among Mexican
Americans (~19%) than among South Americans (~10%) or Cubans (13%–14%) [6]. Assuming
similar differences in adiponectin levels across Hispanic origin groups, the difference between
adiponectin levels in Mexican Americans compared to non-Latino whites would be expected to
be higher than that between a heterogeneous group of Hispanics and non-Latino whites. Second,
although previous studies have consistently reported lower adiponectin levels among Hispanics,
and some have controlled for age, sex, BMI, and waist circumference [3,5,7], none to our knowledge,
has controlled for visceral adiposity as measured by gold-standard CT. Therefore, whether lower
adiponectin levels among Hispanics are explained by higher visceral adiposity remains unknown.
Third, only two studies (our previous study [7] and the MESA study [5]) compared the association
between adiponectin and insulin sensitivity/resistance, and both of these used a surrogate measure
(HOMA-IR) to estimate insulin resistance. Finally, recent data suggest associations between diet
components and adiponectin, and an effect of dietary changes on adiponectin levels in mostly
white European populations [8,9]. In particular, high fiber intake [10,11] and low glycemic load
diets [12] increase adiponectin concentrations. However, these associations have not been explored
in ethnic-minority populations.
The aim of the present study was to test the hypothesis that adiponectin concentrations are
lower in healthy Mexican Americans compared to non-Latino white adults, controlling for visceral
adiposity, and that lower adiponectin in Mexican Americans is associated with lower insulin
sensitivity. In addition, we explored the associations of adiponectin with diet components.
2. Methods
2.1. Study Population
We recruited Mexican American and non-Latino white men and women, 18–60 years of age, with
BMI between 20 and 35 kg/m2 and no evidence of diabetes as determined by a medical history and
screening fasting glucose <126 mg/dL. Eligible Mexican American participants reported having at
least three grandparents who were born in Mexico and non-Latino white participants denied having
any grandparents of Latino descent. Individuals with diabetes or other significant medical conditions
such as heart, kidney, or liver failure were excluded. Women who were pregnant, planning to become
pregnant during the course of the study, or breast feeding were also excluded. The study protocol was
approved by the Colorado Multiple Institutional Review Board and all study participants provided
written informed consent to participate.
2.2. Study Design
We conducted an observational, cross-sectional study. Recruitment of participants was done
through interest meetings and fliers at schools and community centers in Aurora, Colorado, and
through emails and fliers at the University of Colorado Anschutz Medical Campus. Interested
individuals were screened by phone, and then invited to attend a screening visit during which the
study protocol was reviewed and informed consent was obtained. At the screening visit, potential
participants had a medical history, physical exam, and blood tests to rule out significant medical
illness. Eligible individuals returned for a second study visit where they completed the Baecke
physical activity questionnaire [13] and the Block food frequency questionnaire (NutritionQuest,
Berkeley, CA, USA), and had a DXA scan (Hologic Discovery, Hologic, Inc., Bedford, MA, USA).
Participants were then asked to wear a pedometer and log their daily steps for 7 days. Participants
attended a final study visit during which they had a fasting blood draw for measurement of
adiponectin, insulin, and glucose, a frequently-sampled IVGTT [14] for assessment of insulin
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sensitivity measures, and a two-slice CT scan at L2/L3 and L4/L5 for measurement of visceral
adipose tissue (VAT).
2.3. Measurements and Definitions
Laboratory measures were performed by the Colorado Clinical and Translational Sciences
Institute (CCTSI) Core Laboratory. Blood samples were collected in EDTA-containing tubes. Samples
were transported on ice and immediately centrifuged at 20 ˝C at 3000 rev/min for 15 min. The
supernatants were stored in aliquots at ´80 ˝C. Adiponectin and insulin plasma concentrations
were measured by RIA (Millipore, Billerica, MA, USA). Intra- and inter-assay precisions for the
adiponectin assay are 1.78%–3.59% CV and 6.90%–9.25% CV respectively. HOMA2-IR was calculated
from fasting insulin and glucose using the HOMA2 calculator program (University of Oxford, Oxford,
UK, 2004); BMI was calculated as kg/m2; acute insulin response (AIR) and insulin sensitivity (Si)
were calculated using the Bergman MINMOD program [14] with glucose and insulin values obtained
during a frequently-sampled IVGTT. Daily vitamin D intake included intake from both food sources
and dietary supplement intake as reported in the food frequency questionnaire.
2.4. Statistical Analyses
Unadjusted differences in all variables between ethnic groups and gender were evaluated using
two-group t tests. The primary outcome, difference in adiponectin concentrations between ethnic
groups, was further tested using an ANCOVA model controlling for age, gender, BMI, and visceral
adiposity. Additional covariates were added based on clinical relevance or correlation with the
outcome measure where the p value was < 0.01. Association between adiponectin and insulin
sensitivity by ethnicity was evaluated in the same manner. Insulin sensitivity was log transformed
for analysis. Associations between adiponectin and dietary data for the entire cohort were evaluated
using Spearman’s correlation coefficient. SAS version 9.2 (SAS Institute Inc., Cary, NC, USA) was
used for all statistical analyses.
3. Results
A total of 43 individuals were studied. Data for one individual with undetectable circulating
adiponectin (attributed to sample degradation) was excluded from the analyses. Demographic
characteristics and clinical measures of study participants stratified by ethnicity are presented in
Table 1.
Mexican Americans were shorter and had higher BMI, waist circumference, and VAT than
non-Latino whites. Mexican Americans also had higher AIR, lower Si, and lower adiponectin. As
expected, men in both ethnic groups had lower adiponectin than women, but gender differences
were less pronounced among Mexican Americans. Mexican American men and women had lower
adiponectin than their non-Latino white counterparts (4.3 ˘ 1.8 µg/mL vs. 7.7 ˘ 4.2 µg/mL, p = 0.06
in men, 6.7 ˘ 3.8 µg/mL vs. 12.1 ˘ 3.7 µg/mL, p = 0.001 in women) though this difference did not
reach statistical significance in the men.
On multivariate analysis (Table 2), Mexican American ethnicity was associated with ~40% lower
mean adiponectin concentrations (estimate (95% CI): ´4.2 (´6.7, ´1.8) µg/mL) after controlling for
age, gender, BMI, and visceral adiposity. At each BMI level, Mexican American men and women had
lower mean adiponectin compared to their non-Latino white counterparts (Figure 1).
Mexican Americans with low adiponectin had low insulin sensitivity (R2 = 0.42, p < 0.01), but
this association was not observed among non-Latino whites. In contrast to the association between
adiponectin and insulin sensitivity among Mexican Americans, the association between BMI and
insulin sensitivity was not statistically significant among Mexican Americans, and weak (R2 = 0.20,
p < 0.05) among non-Latino whites.
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Table 1. Demographic characteristics and clinical measures by ethnicity.
Variable Combined(n = 42)
Mexican American
(n = 16)
Non-Latino White
(n = 26) p
Age (years) 34.5 ˘ 9.1 35.0 ˘ 6.3 34.2 ˘ 10.5 0.77
Sex (women/men) 28/14 10/6 18/8 0.66
Height (cm) 166.7 ˘ 11.0 161.7 ˘ 9.4 169.8 ˘ 11.0 0.02
Weight (kg) 73.3 ˘ 11.8 73.0 ˘ 10.2 73.5 ˘ 12.9 0.88
BMI (kg/m2) 26.4 ˘ 3.9 27.9 ˘ 3.5 25.5 ˘ 3.9 0.04
Waist circumference * (cm) 85.6 ˘ 9.3 89.4 ˘ 8.5 83.2 ˘ 9.0 0.03
SA * (cm2) 288 ˘ 110 319 ˘ 89 271 ˘ 117 0.19
VAT * (cm2) 71 ˘ 45 92 ˘ 48 60 ˘ 40 0.03
VAT/SAT 0.25 ˘ 0.15 0.30 ˘ 0.17 0.23 ˘ 0.14 0.17
Lean mass * (kg) 48.6 ˘ 10.2 47.4 ˘ 9.8 49.3 ˘ 10.5 0.57
Fasting glucose (mmol/L) 5.0 ˘ 0.4 5.1 ˘ 0.3 4.9 ˘ 0.4 0.02
Fasting insulin (pmol/L) 94.5 ˘ 61.8 120.1 ˘ 77.8 78.5 ˘ 43.8 0.03
HOMA2-IR 2.0 ˘ 1.2 2.5 ˘ 1.5 1.7 ˘ 0.9 0.03
AIR (µU/mL ˆ 10 min) 667 ˘ 444 861 ˘ 497 548 ˘ 369 0.02
Si (ˆ10´4/min/µU/mL) 3.8 ˘ 2.1 2.7 ˘ 1.7 4.6 ˘ 1.9 0.002
DI (ˆ10´4/min) 2174 ˘ 1674 2078 ˘ 2201 2233 ˘ 1296 0.78
CRP (mg/L) 1.6 ˘ 1.7 2.2 ˘ 2.4 1.2 ˘ 0.9 0.09
Leptin (ng/mL) 13.3 ˘ 10.6 15.2 ˘ 11.2 12.2 ˘ 10.2 0.4
Adiponectin (µg/mL) 8.9 ˘ 4.5 5.8 ˘ 3.3 10.7 ˘ 4.2 0.0003
LAR (ng/µg) 1.8 ˘ 1.6 2.8 ˘ 2.0 1.3 ˘ 0.9 0.001
Notes: Mean ˘ SD; AIR= Acute Insulin Response; DI, Disposition Index; LAR = leptin-adiponectin ratio;
SAT = subcutaneous adipose tissue; Si = Insulin Sensitivity; VAT = visceral adipose tissue * Up to 2 cases missing.
Table 2. ANCOVA with adiponectin as the dependent variable.
Model 1 Model 2
Variable EST (95% CI) EST (95% CI)
Mexican American ethnicity ´4.6 (´7.2, ´2.0) ´4.2 (´6.7, ´1.8)
Male gender ´2.2 (´0.4, ´4.7)
Age 0.2 (0.03, 0.3)
BMI 0.5 (0.1, 1.0)
VAT ´0.1 (´0.1, ´0.01)
R2 0.23 0.54
Figure 1. Differences in adiponectin concentrations between Mexican Americans and non-Latino
Whites across BMI Ranges. Symbols represent adiponectin concentrations and BMI for Mexican
American women ( ), men (), and non-Latino white women (#), and men (˝). Lines represent
linear regression lines for Mexican Americans (solid line) and non-Latino whites (dashed lines) with
higher/longer lines representing women of each group. Differences in intercepts: p < 0.001 for
women, p = 0.20 for men).
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Self-reported dietary intake data obtained via food-frequency questionnaire was compared
for the two ethnic groups (Table 3; reported per 1000 kilocalories (kcal)). There were no ethnic
differences in daily caloric intake or in major macronutrient distributions (carbohydrates, protein,
and fat). However, ethnic differences were observed in macronutrient components. Mexican
Americans reported higher servings of grains (including whole grains), but lower servings of fruits
and vegetables compared to non-Latino whites. Similarly, Mexican Americans reported higher intake
of bean fiber and lower intake of fruit and vegetable fiber. Mexican Americans also reported higher
intake of trans fats, but intake of saturated fat was similar in the two groups. Intakes of dairy, total
fiber, glycemic index (GI), and glycemic load (GL), were also similar between the two ethnic groups.
Table 3. Daily dietary measures by ethnicity and gender.
Mexican American (n = 16) Non-Latino White (n = 26) p 1
Energy (kcal) 1960 ˘ 790 1734 ˘ 621 0.31
Carbohydrate (g/1000 kcal) 131.0 ˘ 18.2 122.0 ˘ 18.3 0.13
Protein (g/1000 kcal) 39.2 ˘ 8.1 38.0 ˘ 6.6 0.60
Fat (g/1000 kcal) 36.4 ˘ 5.4 37.7 ˘ 6.0 0.49
Grain servings (per 1000 kcal) 3.3 ˘ 1.1 2.6 ˘ 0.8 0.01
Whole grain servings (per 1000 kcal) 1.0 ˘ 0.8 0.4 ˘ 0.4 0.001
Fruit servings (per 1000 kcal) 0.5 ˘ 0.5 1.0 ˘ 0.6 0.02
Vegetable servings (per 1000 kcal) 1.0 ˘ 0.6 1.7 ˘ 1.1 0.03
Meat servings (per 1000 kcal) 1.6 ˘ 0.5 1.1 ˘ 0.3 0.001
Dairy servings (per 1000 Kcal) 0.8 ˘ 0.5 0.8 ˘ 0.5 0.66
Fat servings (per 1000 kcal) 2.0 ˘ 0.9 1.7 ˘ 0.7 0.23
Fiber (g/1000 kcal) 9.8 ˘ 2.9 10.4 ˘ 3.5 0.57
Bean fiber (g/1000 kcal) 2.2 ˘ 1.5 1.3 ˘ 0.7 0.008
Fruit/veg. fiber (g/1000 kcal) 2.4 ˘ 1.2 4.7 ˘ 2.8 0.005
Grain fiber (g/1000 kcal) 4.7 ˘ 1.6 4.3 ˘ 2.6 0.53
GI, glucose 49.9 ˘ 2.1 48.8 ˘ 3.2 0.23
GL, glucose (per 1000 kcal) 60.6 ˘ 9.8 54.7 ˘ 10.8 0.83
Saturated fat (g/1000 kcal) 11.4 ˘ 2.3 11.6 ˘ 2.8 0.81
Trans fat (g/1000 kcal) 1.3 ˘ 0.4 1.1 ˘ 0.3 0.03
Vitamin D (IU/1000 kcal) 147 ˘ 93 198 ˘ 157 0.24
Omega 3 FA (g/1000 kcal) 0.7 ˘ 0.2 0.9 ˘ 0.3 0.16
Note: 1 Based on a two-group t test for ethnic groups pooling across gender.
In univariate analyses of dietary data for the entire cohort, several dietary factors were associated
with higher adiponectin including higher fruit and vegetable fiber intake (r = 0.50, p = 0.0007), lower
glycemic index r = ´0.47, p = 0.0017), fewer grain servings (r = ´0.42, p = 0.005), and lower trans fat
intake (r = ´0.4, p = 0.008).
Compared to individuals in the lowest gender-specific quartiles for fruit/vegetable fiber,
individuals in the highest quartiles had adiponectin concentrations that were 4.7 µg/mL higher,
p = 0.03. Conversely, compared to individuals in the lowest gender-specific quartiles for glycemic
index, grain servings, and trans fat intake, individuals in the highest quartiles had adiponectin
concentrations that were 5.6 µg/mL, 4.6 µg/mL, and 5.8 µg/mL lower (p = 0.005, p = 0.01 and
p = 0.001) respectively (Figure 2). On multivariate analyses including ethnicity, gender, BMI, and
each individual dietary factor, dietary glycemic index, grain servings, and vitamin D remained
independently associated with adiponectin levels (p-values 0.01, 0.01, and 0.007 respectively), while
associations with fruit/vegetable fiber and trans fat intake did not reach statistical significance
(p-values 0.1 and 0.15).
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Figure 2. Adiponectin concentrations among individuals in lowest and highest gender-specific
quartile for each dietary component. Mean and SEM of adiponectin concentrations for individuals
in the lowest (Q1, white bar) and highest (Q4, shaded bar) gender-specific quartile for intake of each
dietary factor. GI, glycemic index.
4. Discussion
Our findings confirm previous observations of lower adiponectin levels in Mexican Americans
compared to non-Latino whites, and verify that this difference remains after controlling for visceral
adiposity. Furthermore, our finding of a stronger association between adiponectin and insulin
sensitivity among young healthy Mexican Americans compared to non-Latino whites suggests that
adiponectin may be a stronger contributor to diabetes risk in the former population. Finally, our
findings of associations between adiponectin and dietary components suggest a need for future
research to explore the effects of dietary components on adiponectin, insulin sensitivity, and diabetes
risk in Mexican Americans.
Interpretation of our findings is limited by the observational nature of the study which prevents
us from establishing causation in the observed associations. The relatively small sample size
precluded a more thorough analysis of all the mechanisms involved in adiponectin regulation.
Specifically, a larger sample size would be needed to definitively establish that dietary intake is
associated with adiponectin after controlling for all potential confounders. We measured multiple
associations between adiponectin and dietary components, and therefore some of associations having
significant p values may have occurred by chance. We did not measure the expression of adiponectin
receptors which likely also contribute to adiponectin’s insulin-sensitizing actions and may vary by
ethnicity. Lastly, we did not measure concentrations of high-molecular weight adiponectin which is
believed to be the active form of the molecule. Though a study of genetics effects on adiponectin
regulation was beyond the scope of this work, we attempted to limit genetic variability by limiting
our focus on Mexican Americans rather than a more heterogeneous Hispanic population. Another
strength of the study is accurate measures of visceral adiposity by CT rather than using waist
circumference as a surrogate marker, and of insulin sensitivity by frequently-sampled IVGTT rather
than estimating insulin sensitivity/resistance by HOMA alone.
Adiponectin concentrations are known to vary by ethnicity, and lower mean adiponectin
concentrations have previously been reported in different ethnic/racial subgroups including
Hispanics. Adiponectin was lower in ethnic/racial minorities, including Hispanics, in the Diabetes
Prevention Program study after adjustment for age, BMI, and waist circumference [3]. Our findings
are also consistent with those of the MESA study [5] in which adiponectin concentrations were
lower in Hispanic compared to non-Latino white subjects after controlling for BMI. However, neither
of these studies controlled for ethnic differences in visceral adiposity. Observed ethnic/racial
differences in adiponectin concentrations in these two studies are more modest than those observed
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in our present study. However, the Hispanic groups in both of these studies were not limited to
Mexican Americans and included other Hispanic-origin groups with lower risk of diabetes (i.e.,
South Americans and Cubans) that would be expected to have higher adiponectin concentrations
than Mexican Americans. We have previously reported that among patients with hypertension and
other cardiovascular disease risk factors, Mexican Americans have lower adiponectin concentrations
than non-Latino whites, after controlling for BMI and waist circumference [7]. Our present report
expands our observations to young, healthy, community-dwelling individuals, and contributes to
the existing evidence that ethnic differences in adiponectin are not due to differences in adiposity
measures including visceral adiposity.
Adiponectin is believed to improve insulin sensitivity through a number of different
mechanisms. In addition, adiponectin has potent anti-apoptotic effects which are believed to
prevent lipid-induced pancreatic beta cell apoptosis [15]. Both of these actions would be expected
to be protective against diabetes. Consistent with this evidence, lower adiponectin is associated
with incident diabetes across diverse populations [2,4]. However, it has also been suggested that
adiponectin concentrations are themselves regulated by insulin and that low adiponectin observed
in settings of low insulin sensitivity are due to compensatory hyperinsulinemia [16]. Thus, the
directionality of the association between adiponectin and insulin sensitivity remains in question.
Ours is a correlational study and does not shed additional light on this relationship. However,
our findings support the utility of adiponectin over adiposity measures as an indicator of insulin
sensitivity and diabetes risk among Mexican Americans.
Multiple recent studies have examined associations between dietary factors and adiponectin
and the effects of dietary modifications on adiponectin concentrations [8,9,17]. To our knowledge,
ours is the first to examine associations between dietary factors and adiponectin among Mexican
Americans. Our findings of lower adiponectin in association with lower intake of fruit and vegetable
fiber, higher dietary glycemic index, and higher intakes of grains and trans fat, are consistent with
previous observations among non-Latino whites [18,19]. In the Nurses’ Health Study of women
with type 2 diabetes [20] and in the Health Professionals’ Follow-up Study of men with type 2
diabetes [18], adiponectin was lower among individuals reporting diets high in glycemic index and
glycemic load, and higher among individuals reporting high cereal and fruit fiber intake. In another
study [21], adiponectin concentrations decreased from baseline after consumption of a high fat meal
in non-diabetic subjects and in patients with type 2 diabetes. In patients with diabetes, adiponectin
concentrations also decreased after consumption of a high carbohydrate, low-fiber meal, but not
after consumption of a high carbohydrate, high-fiber meal. Our finding of lower adiponectin with
higher whole grain intake was unexpected and is counterintuitive. This observation may reflect
an effect of the specific whole grain foods consumed by the individuals studied, or other related
dietary components that we did not measure. Our findings suggest that dietary modifications may
improve adiponectin concentrations and highlight the need for future more definitive studies in this
research area.
While it appears clear that adiponectin is decreased in Mexican Americans, the molecular and
environmental regulators involved in this ethnic difference are unknown. The question of whether
adiponectin concentrations can be increased through dietary modification in Mexican Americans and
other populations with low adiponectin remains unanswered. Furthermore, whether or not such
increases in adiponectin would be associated with improved insulin sensitivity and decreased risk
for diabetes is unknown. Future research to address these questions is warranted.
5. Conclusions
In conclusion, the present study showed that Mexican Americans have lower circulating
adiponectin levels than non-Latino whites, independent of differences in adiposity. Lower
adiponectin among Mexican Americans was associated with lower insulin sensitivity which is a
known risk factor for diabetes. Associations between dietary intake and adiponectin where observed,
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suggesting that dietary modifications may be a potential tool for improved insulin sensitivity and
decreased risk for diabetes among Mexican Americans.
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